Status:
COMPLETED
DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022
Lead Sponsor:
Cosmetique Active International
Conditions:
Dandruff
Eligibility:
All Genders
12+ years
Brief Summary
The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS
Eligibility Criteria
Inclusion
- Patients with dandruff or seborrheic dermatitis
- All hair types
- All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic)
- Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use)
- Patients willing to provide written informed consent
Exclusion
- Under 12 years old
- Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles.
- History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo
- History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in.
- Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting.
- Inability to attend all study visits and follow treatment regimen
Key Trial Info
Start Date :
July 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2023
Estimated Enrollment :
5131 Patients enrolled
Trial Details
Trial ID
NCT05989633
Start Date
July 4 2022
End Date
June 29 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marta Sar Pormian
Warsaw, Poland